🔎 Trials Near Me

Akèy › Kansè renn › Texas › Dallas

Etid klinik pou Kansè renn nan Dallas, TX

9 etid pou Kansè renn ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Ap rekriteFaz 1
  • Texas Oncology, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06234605

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 3
  • Research Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07011719

A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)

Ap rekriteFaz 1
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07401875

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Ap rekriteFaz 1/2
  • University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
  • University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
  • University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07227415

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 1
  • NEO-811 Dallas Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT07300241

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Ap rekriteFaz 1
  • UT Southwestern Simmons Cancer Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06026410

A Study of VET3-TGI in Patients With Solid Tumors

Ap rekriteFaz 1
  • Mary Crowley Cancer Research, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Apr 7, 2026 · NCT06444815

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

Ap rekriteVolontè an sante akeyi
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT04623502

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Dallas
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè renn nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.